NCT01392352 2020-02-13HYPAZCambridge University Hospitals NHS Foundation TrustPhase 2 Terminated31 enrolled
NCT01130623 2017-07-02A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid TumorsNational Institutes of Health Clinical Center (CC)Phase 1 Withdrawn